Quetiapine
Schizophrenia, Bipolar I disorder manic episodes, Bipolar disorder, depressive episodes
Boxed warning
- WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS; and SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning. Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Quetiapine is not approved for elderly patients with dementia-related psychosis ( 5.1 ) Suicidal Thoughts and Behaviors Increased risk of suicidal ... (see full label)
Indications
- Schizophrenia
- Bipolar I disorder manic episodes
- Bipolar disorder, depressive episodes
Adult dosing
- schizophrenia: dose: 25; unit: mg; route: PO; interval: twice daily; 150 to 750 mg/day; fixed: true; labelExcerpt: Schizophrenia-Adults ( 2.2 ) 25 mg twice daily 150 to 750 mg/day 750 mg/day
- bipolar mania: dose: 50; unit: mg; route: PO; interval: twice daily; 400 to 800 mg/day; fixed: true; labelExcerpt: Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex ( 2.2 ) 50 mg twice daily 400 to 800 mg/day 800 mg/day
- bipolar depression: dose: 50; unit: mg; route: PO; interval: once daily at bedtime; 300 mg/day; fixed: true; labelExcerpt: Bipolar Depression-Adults ( 2.2 ) 50 mg once daily at bedtime 300 mg/day 300 mg/day
Pediatric dosing
- schizophrenia: dose: 25; unit: mg; route: PO; interval: twice daily; 400 to 800 mg/day; fixed: true; labelExcerpt: Schizophrenia-Adolescents (13 to 17 years) ( 2.2 ) 25 mg twice daily 400 to 800 mg/day 800 mg/day
- bipolar mania: dose: 25; unit: mg; route: PO; interval: twice daily; 400 to 600 mg/day; fixed: true; labelExcerpt: Bipolar Mania-Children and Adolescents (10 to 17 years), Monotherapy ( 2.2 ) 25 mg twice daily 400 to 600 mg/day 600 mg/day
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Start at 25 mg/day and increase in increments of 25 mg/day to 50 mg/day as needed.
Contraindications
- Known hypersensitivity to quetiapine or any components
Clinical pearls
- Increased mortality risk in elderly patients with dementia-related psychosis; not approved for this use.
- Monitor for metabolic changes including hyperglycemia, dyslipidemia, and weight gain.
- Monitor for suicidal thoughts and behaviors in young adults, children, and adolescents.
- Requires periodic monitoring for cataracts and blood pressure (in children).
Source and review
- DailyMed label (quetiapine fumarate), Set ID 227b8b2b-a238-efb4-e063-6394a90acc7e, effective 2026-08-17. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties